Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Anemia

Free Subscription Articles published in Transfusion Retrieve available abstracts of 79 articles: HTML format

Single Articles

September 2025
1. ALMAHMOUD K, Bauer S, Sherry C, Mancuso C, et al
   Provider uptake of the anemia protocol across different intensive care units over 5 years in urban medical center.
   Transfusion. 2025 Sep 17. doi: 10.1111/trf.18415.
   PubMed     Abstract available
   
   
   July 2025
2. TORDON B, Alhomsi N, Iqbal A, Gangji A, et al
   Rare case of warm IgM autoimmune hemolytic anemia.
   Transfusion. 2025 Jul 24. doi: 10.1111/trf.18353.
   PubMed     Abstract available
   
   
   
3. LIANG Y, Qu W, Lu J, Liang Y, et al
   Establishment and application of a new method for the detection of drug antibodies by flow cytometry.
   Transfusion. 2025;65:1335-1343.
   PubMed     Abstract available
   
   
   June 2025
4. ABRAMS HR, Saifee NH, Miller WS 3rd, Cortez A, et al
   Alloimmunization as a barrier to gene therapy in sickle cell disease.
   Transfusion. 2025;65:1035-1039.
   PubMed     Abstract available
   
   
   
5. HUSSAIN S, Linder G, Press CA, Vossough A, et al
   Hypertension and encephalopathy in a pediatric patient following red blood cell transfusion.
   Transfusion. 2025;65:1196-1202.
   PubMed     Abstract available
   
   
   May 2025
6. DE BOER ECW, Mulder FVM, Neri S, Wiskerke-van Stuijvenberg M, et al
   Vesiculation as potential novel pathogenic mechanism in autoimmune hemolytic anemia.
   Transfusion. 2025 May 12. doi: 10.1111/trf.18270.
   PubMed     Abstract available
   
   
   
7. ALKHATEB R, Mazzolini K, Prajapati VP, Harrison C, et al
   How I do it: An institutional protocol for the management of RhD negative women who receive RhD positive blood.
   Transfusion. 2025;65 Suppl 1:S320-S327.
   PubMed     Abstract available
   
   
   
8. BENJAMIN RJ, Pitman JP, Karim C, Huang S, et al
   A novel acridine flow cytometry marker to track post-transfusion amustaline/glutathione pathogen-reduced red blood cell survival in sickle cell disease patients.
   Transfusion. 2025;65:909-920.
   PubMed     Abstract available
   
   
   
9. QIU A, Fliginger D, Feit Y, Hassan F, et al
   Estimating the prevalence of preoperative iron deficiency and its impact on red blood cell transfusion in adolescents undergoing scoliosis surgery: A pilot study.
   Transfusion. 2025;65:851-857.
   PubMed     Abstract available
   
   
   
10. MALTA B, Cintho Ozahata M, Gomes Moura IC, Amorim L, et al
    Clinics and genetics of hyperhemolysis syndrome in patients with sickle cell disease.
    Transfusion. 2025;65:992-1000.
    PubMed     Abstract available
    
    
    
11. HAN H, Hensch L, Lei I, Fasipe T, et al
    Outcomes on the use of hyperhemolysis prophylaxis in pediatric sickle cell disease patients with history of hyperhemolysis syndrome.
    Transfusion. 2025;65:1001-1006.
    PubMed     Abstract available
    
    
    April 2025
12. OKADA H, Stewart KE, Shettar SS, Kulesus KJ, et al
    Association of antepartum anemia and red blood cell mass with racial and ethnic disparities in transfusion rates after cesarean delivery: A retrospective cohort study.
    Transfusion. 2025 Apr 25. doi: 10.1111/trf.18260.
    PubMed     Abstract available
    
    
    
13. LOOBEEK D, Pacnerova L, Twisk J, So-Osman C, et al
    How do I analyze the role of red blood cell transfusions on clinical outcome in anemic patients? Disentangling the effect of red blood cell transfusions from pre-operative anemia on post-operative outcome.
    Transfusion. 2025 Apr 3. doi: 10.1111/trf.18224.
    PubMed     Abstract available
    
    
    March 2025
14. UMINSKI K, Perelman I, Mack J, Tinmouth A, et al
    Red blood cell utilization in patients with sickle cell disease: A Canadian single-center experience.
    Transfusion. 2025;65:476-484.
    PubMed     Abstract available
    
    
    February 2025
15. UMINSKI K, Perelman I, Tinmouth AT, Mack J, et al
    Use of automated isovolemic hemodilution red-cell exchange in patients with sickle cell disease: A Canadian single center experience.
    Transfusion. 2025;65:325-332.
    PubMed     Abstract available
    
    
    
16. BRONS N, Kaspersen KA, Bay JT, Dowsett J, et al
    Iron deficiency and infection risk in Danish blood donors.
    Transfusion. 2025;65:286-296.
    PubMed     Abstract available
    
    
    
17. KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
    Comparative efficacy of liberal and restrictive blood transfusion strategies in anemic patients with acute myocardial infarction: A systematic review and meta-analysis of randomized controlled trials.
    Transfusion. 2025;65:260-266.
    PubMed     Abstract available
    
    
    January 2025
18. CASTONGUAY M, Bernard L, Corriveau M, Castonguay A, et al
    Approach to autologous stem cell transplantation in a patient with severe cold agglutinin disease, a case report.
    Transfusion. 2025 Jan 28. doi: 10.1111/trf.18147.
    PubMed     Abstract available
    
    
    
19. DEI-ADOMAKOH Y, Olayemi E, Telke S, Asamoah-Akuoko L, et al
    Impact of iron supplementation among anemic voluntary first-time blood donors: Results from the BLOODSAFE pilot trial in Ghana.
    Transfusion. 2025;65:131-139.
    PubMed     Abstract available
    
    
    December 2024
20. JONES JM, Wool J, Crowe EP, Bloch EM, et al
    Longitudinal outcomes of chronically transfused adults with sickle cell disease and a history of childhood stroke.
    Transfusion. 2024;64:2260-2269.
    PubMed     Abstract available
    
    
    
21. YURTSEVER N, Tong N, Geetha S, Nandi V, et al
    Post-exchange neutrophil count, but not post-hematocrit, predicts endogenous erythropoiesis in patients with sickle cell disease undergoing chronic red cell exchange.
    Transfusion. 2024;64:2270-2278.
    PubMed     Abstract available
    
    
    November 2024
22. NICKEL RS, Margulies S, Panchapakesan K, Chorvinsky E, et al
    Adding hydroxyurea to chronic transfusion therapy for sickle cell anemia reduces transfusion burden.
    Transfusion. 2024 Nov 24. doi: 10.1111/trf.18073.
    PubMed     Abstract available
    
    
    
23. BHASIN N, LeBlanc DM, Yates S, Eichbaum Q, et al
    Physician perspectives about the diagnosis and management of acute chest syndrome.
    Transfusion. 2024;64:2095-2103.
    PubMed     Abstract available
    
    
    October 2024
24. ADKINS BD, Kaylani SZ, Nero A, Ibrahim IF, et al
    How do we manage hyperhemolysis syndrome.
    Transfusion. 2024;64:1822-1829.
    PubMed     Abstract available
    
    
    
25. KARREGAT J, Meulenbeld A, Abubakar J, Quee FA, et al
    Iron deficiency-related symptoms in non-anemic whole blood donors.
    Transfusion. 2024;64:1920-1930.
    PubMed     Abstract available
    
    
    September 2024
26. FISHER S, Chihuri S, Guglielminotti J, Li G, et al
    Racial and ethnic differences in transfusion rates in adolescent scoliosis surgery: Preoperative anemia as a mediator of disparity.
    Transfusion. 2024 Sep 20. doi: 10.1111/trf.18023.
    PubMed     Abstract available
    
    
    
27. LEE GM, Boyle K, Batchvarova M, Delahunty M, et al
    Red cell exchange modulates neutrophil degranulation responses in sickle cell disease.
    Transfusion. 2024;64:1752-1761.
    PubMed     Abstract available
    
    
    
28. SUN Q, Karafin MS, Garrett ME, Li Y, et al
    A genome-wide association study of alloimmunization in the TOPMed OMG-SCD cohort identifies a locus on chromosome 12.
    Transfusion. 2024;64:1772-1783.
    PubMed     Abstract available
    
    
    August 2024
29. ZAKIEH A, Mercure-Corriveau N, Lanzkron S, Feng X, et al
    Chronic automated red cell exchange therapy for sickle cell disease.
    Transfusion. 2024;64:1509-1519.
    PubMed     Abstract available
    
    
    
30. DENOON RB, Soares Ferreira Junior A, Tuttle B, Onwuemene OA, et al
    Therapeutic plasma exchange for sickle cell disease acute complications: A systematic review.
    Transfusion. 2024;64:1570-1587.
    PubMed    
    
    
    July 2024
31. BAYKARA Y, Nixon C, Pavlovich A, Akgun Y, et al
    Unpacking the utility of euvolemic automated transfusion in sickle cell disease.
    Transfusion. 2024;64:1381-1382.
    PubMed    
    
    
    
32. SRIVASTAVA K, Yin Q, Makuria AT, Rios M, et al
    CD59 gene: 143 haplotypes of 22,718 nucleotides length by computational phasing in 113 individuals from different ethnicities.
    Transfusion. 2024;64:1296-1305.
    PubMed     Abstract available
    
    
    
33. SEEBER P, Trentino KM, Murray K, Lucas M, et al
    A further update on mortality and morbidity in patients with very low hemoglobin levels who decline blood transfusion.
    Transfusion. 2024;64:1198-1206.
    PubMed     Abstract available
    
    
    
34. JALINK M, Yan MTS, Cohn CS, Eichbaum QG, et al
    Systematic review for the serological testing for cold agglutinins: The BEST collaborative study.
    Transfusion. 2024;64:1331-1349.
    PubMed    
    
    
    June 2024
35. YEE MEM, Covington ML, Zerra PE, McCoy JW, et al
    Survival of transfused red blood cells from a donor with alpha-thalassemia trait in a recipient with sickle cell disease.
    Transfusion. 2024;64:1109-1115.
    PubMed     Abstract available
    
    
    
36. LINSTROM M, Musekwa E, Nell EM, de Waard L, et al
    The influence of hematological profiles on the transfusion management and mortality risk of mothers presenting to the obstetric unit of a South African tertiary medical facility.
    Transfusion. 2024;64:986-997.
    PubMed     Abstract available
    
    
    May 2024
37. RAMSEY G, Barriteau CM
    Estimating the serological underrecognition of patients with weak or partial RHD variants.
    Transfusion. 2024;64:920-928.
    PubMed     Abstract available
    
    
    
38. WERNEIWSKI K, Gehrie EA
    Development of an interactive mapping tool to estimate where resources for people living with sickle cell disease may be needed most.
    Transfusion. 2024;64:772-774.
    PubMed    
    
    
    
39. YEE MEM, Zerra PE, McCoy JW, Covington ML, et al
    Post-transfusion biotin-labeled red blood cell survival studies in pediatric sickle cell disease with antibodies of uncertain significance.
    Transfusion. 2024;64:800-807.
    PubMed     Abstract available
    
    
    April 2024
40. JAVANBAKHT A, Schneider TM, Hendrickson JE
    Red blood cell alloimmunization in patients on extracorporeal membrane oxygenation.
    Transfusion. 2024;64:761-762.
    PubMed    
    
    
    
41. ROGERS K, Alsawas M, Chapman J, Schlueter AJ, et al
    Using the daily rate of rise in hemoglobin S to manage RBC depletion/exchange treatment in sickle cell disease.
    Transfusion. 2024;64:685-692.
    PubMed     Abstract available
    
    
    
42. LEIVA-TORRES GA, Cigna M, Constanzo-Yanez J, St-Louis M, et al
    Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited.
    Transfusion. 2024;64:716-726.
    PubMed     Abstract available
    
    
    
43. CHASE RC, Koop AH, Shaikh M, Imperial RJ, et al
    Successful treatment of severe passenger lymphocyte syndrome with efgartigimod synergy.
    Transfusion. 2024;64:755-760.
    PubMed     Abstract available
    
    
    
44. WANG L, Rochon ER, Gingras S, Zuchelkowski BE, et al
    Functional effects of an African glucose-6-phosphate dehydrogenase (G6PD) polymorphism (Val68Met) on red blood cell hemolytic propensity and post-transfusion recovery.
    Transfusion. 2024;64:615-626.
    PubMed     Abstract available
    
    
    March 2024
45. JORGENSEN CC, Michelsen C, Petersen T, Kehlet H, et al
    Preoperative hemoglobin thresholds for increased risk of "medical" complications in fast-track total hip and knee arthroplasty, a secondary analysis of a machine-learning algorithm.
    Transfusion. 2024;64:438-442.
    PubMed     Abstract available
    
    
    
46. ISRAELYAN N, Vege S, Friedman DF, Zhang Z, et al
    RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.
    Transfusion. 2024;64:526-535.
    PubMed     Abstract available
    
    
    February 2024
47. CAO J, Lu S, Luo D, Pei R, et al
    Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab.
    Transfusion. 2024 Feb 13. doi: 10.1111/trf.17743.
    PubMed     Abstract available
    
    
    
48. PETERMANN S, Mayer V, Carbol A, Opitz A, et al
    Compound heterozygosity induces a rare Gerbich-negative phenotype in an immunized blood donor.
    Transfusion. 2024;64:406-411.
    PubMed     Abstract available
    
    
    
49. MO A, Wood E, Shortt J, Charlton A, et al
    Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n-of-1 trial of weekly-interval red cell transfusion in myelodysplastic syndromes.
    Transfusion. 2024;64:236-247.
    PubMed     Abstract available
    
    
    January 2024
50. CIGNA M, Leiva-Torres GA, Baillargeon N, Yanez JC, et al
    Management of a patient with sickle cell disease and multiple red blood cell alloantibodies in preparation for a hematopoietic stem cell transplantation.
    Transfusion. 2024 Jan 11. doi: 10.1111/trf.17715.
    PubMed     Abstract available
    
    
    
51. BRANCAMP R, Hughes CE, Dar A, Polic A, et al
    Homozygous SPTA1-associated hereditary pyropoikilocytosis presenting as hydrops fetalis.
    Transfusion. 2024;64:189-193.
    PubMed     Abstract available
    
    
    
52. LIPMAN T, Bienz MN, Pendergrast J, Cserti-Gazdewich C, et al
    Unexpected difficulty in performance of a monocyte monolayer assay when using RBCs from a patient with sickle cell disease.
    Transfusion. 2024;64:4-5.
    PubMed    
    
    
    
53. STEVENS-HERNANDEZ CJ, Gyorffy G, Meli A, New HV, et al
    Vesiculation in irradiated and cation-leaky-stored red blood cells.
    Transfusion. 2024;64:150-161.
    PubMed     Abstract available
    
    
    December 2023
54. CALJE E, Oyston C, Wang Z, Bloomfield F, et al
    The fatigue after infusion or transfusion pilot trial and feasibility study: A three-armed randomized pilot trial of intravenous iron and blood transfusion for the treatment of postpartum anemia.
    Transfusion. 2023 Dec 27. doi: 10.1111/trf.17621.
    PubMed     Abstract available
    
    
    
55. MERCURE-CORRIVEAU N, Crowe EP, Vozniak S, Feng X, et al
    Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload.
    Transfusion. 2023 Dec 8. doi: 10.1111/trf.17613.
    PubMed     Abstract available
    
    
    
56. CROWE EP, Hasan R, Saifee NH, Bakhtary S, et al
    How do we perform intrauterine transfusions?
    Transfusion. 2023;63:2214-2224.
    PubMed     Abstract available
    
    
    
57. KAYANO SS, Santana PV, Colella R, Colella MP, et al
    Lower platelet count and metastatic tumor are associated with increased risk of spontaneous bleeding in critically ill patients with cancer: An observational study.
    Transfusion. 2023;63:2311-2320.
    PubMed     Abstract available
    
    
    November 2023
58. RYDEN J, Clements M, Wikman A, Hellstrom-Lindberg E, et al
    Red blood cell alloimmunization in myelodysplastic syndromes: Associations with sex, DAT-positivity, and increased transfusion needs.
    Transfusion. 2023;63:2040-2051.
    PubMed     Abstract available
    
    
    October 2023
59. GOLLAMUDI J, Dasgupta SK, Thiagarajan P
    Erythrophagocytosis in autoimmune immunoglobulin A-mediated hemolysis.
    Transfusion. 2023;63:1978-1982.
    PubMed     Abstract available
    
    
    September 2023
60. ABELS E, Jacobs JW, Prior D, Willets LC, et al
    Passive transfer of alloantibodies through breast milk as a mediator of hemolytic anemia.
    Transfusion. 2023 Sep 14. doi: 10.1111/trf.17548.
    PubMed     Abstract available
    
    
    August 2023
61. SOTOLONGO G, Poisson JL
    Increased red blood cell alloimmunization rates in transfused aplastic anemia and myelofibrosis patients.
    Transfusion. 2023 Aug 30. doi: 10.1111/trf.17529.
    PubMed     Abstract available
    
    
    
62. LASOCKI S, Delahaye D, Fuks D, Savoie PH, et al
    Management of perioperative iron deficiency anemia as part of patient blood management in France: A budget impact model-based analysis based on real world data.
    Transfusion. 2023 Aug 23. doi: 10.1111/trf.17495.
    PubMed     Abstract available
    
    
    
63. ARYA S, Xiang T, Tang GH, Pavenski K, et al
    Including the patient in patient blood management: Development and assessment of an educational animation tool.
    Transfusion. 2023;63:1488-1494.
    PubMed     Abstract available
    
    
    July 2023
64. ABDELHAY A, Mahmoud AA, Ammari O, Dalbah R, et al
    Outcomes of therapeutic plasma exchange in severe autoimmune hemolytic anemia hospitalizations: An analysis of the National Inpatient Sample.
    Transfusion. 2023 Jul 3. doi: 10.1111/trf.17445.
    PubMed     Abstract available
    
    
    
65. WEBB CB, Yates SG, Sarode R, Kim J, et al
    Plasma exchange-A useful adjunct therapy to red cell exchange in patients with sickle cell disease and multiorgan dysfunction.
    Transfusion. 2023;63:1384-1390.
    PubMed     Abstract available
    
    
    
66. HAW J, Walrond J, Jayachandran J, Dordunoo D, et al
    Sickle cell disease and the need for blood: Barriers to donation for African, Caribbean, and Black young adults in Canada.
    Transfusion. 2023;63:1324-1332.
    PubMed     Abstract available
    
    
    June 2023
67. DESIMONE RA, Plimier C, Goel R, Hendrickson JE, et al
    Associations of donor, component, and recipient factors on hemoglobin increments following red blood cell transfusion in very low birth weight infants.
    Transfusion. 2023 Jun 30. doi: 10.1111/trf.17468.
    PubMed     Abstract available
    
    
    
68. WALL E, Bolster L
    Complications of red cell exchange for anemia management in patients with transfusion-dependent thalassemia.
    Transfusion. 2023 Jun 15. doi: 10.1111/trf.17419.
    PubMed     Abstract available
    
    
    
69. STEFFEN KM, Spinella PC, Holdsworth LM, Ford M, et al
    Factors influencing pediatric transfusion: A complex decision impacting quality of care.
    Transfusion. 2023;63:1151-1160.
    PubMed     Abstract available
    
    
    May 2023
70. CARTER PW, Dunham AJ
    Modeling hemoglobin levels of patients chronically transfused with red blood cells.
    Transfusion. 2023;63:952-959.
    PubMed     Abstract available
    
    
    
71. SHAULOV A, Rund D, Filon D, Nachmias B, et al
    Successful treatment with plasma exchange in life-threatening hyperhemolytic syndrome unrelated to sickle cell disease.
    Transfusion. 2023;63:1100-1106.
    PubMed     Abstract available
    
    
    
72. YAZER MH, Spinella PC, Sperry J, Triulzi DJ, et al
    Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients.
    Transfusion. 2023;63 Suppl 3:S54-S59.
    PubMed     Abstract available
    
    
    April 2023
73. GOEL R, Roubinian NH, Bembea MM
    Disentangling the causes of RBC loss and anemia in ECMO patients: Some questions answered?
    Transfusion. 2023 Apr 10. doi: 10.1111/trf.17347.
    PubMed    
    
    
    March 2023
74. JUTRAS C, Sauthier M, Tucci M, Trottier H, et al
    Prevalence and determinants of anemia at discharge in pediatric intensive care survivors.
    Transfusion. 2023 Mar 12. doi: 10.1111/trf.17309.
    PubMed     Abstract available
    
    
    
75. COSTA V, Mercure-Corriveau N, Gourneau J, Tobian AAR, et al
    Transfusion-transmitted babesiosis in a patient with sickle cell disease undergoing chronic red cell exchange.
    Transfusion. 2023;63:652-655.
    PubMed     Abstract available
    
    
    
76. ALLISON D, Manon L, Vidanovic V, Crane J, et al
    How do we operate a large monthly red blood cell exchange program.
    Transfusion. 2023;63:450-456.
    PubMed     Abstract available
    
    
    
77. CROWDER LA, Cable RG, Spencer BR
    Validity of donor-reported iron supplementation practices obtained at the time of donation.
    Transfusion. 2023;63:470-475.
    PubMed     Abstract available
    
    
    
78. HAJJAJ OI, Cserti-Gazdewich C, Dumevska L, Hanna M, et al
    Reconsidering sickle cell trait testing of red blood cell units allocated to children with sickle cell disease.
    Transfusion. 2023;63:507-514.
    PubMed     Abstract available
    
    
    February 2023
79. HE Y, Gao W, Li Y, Xu C, et al
    A single-center, retrospective analysis of 17 cases of hemolytic disease of the fetus and newborn caused by anti-M antibodies.
    Transfusion. 2023 Feb 2. doi: 10.1111/trf.17249.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.